Plasma levels of amino acids correlate with motor fluctuations in parkinsonism.
暂无分享,去创建一个
J. Pincus | J H Pincus | K M Barry | K. Barry
[1] J. Langston,et al. Permanent human parkinsonism due to 1‐methy 1–4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) , 1985, Neurology.
[2] Modification of Parkinson's disease by long-term levodopa treatment. , 1986, Archives of neurology.
[3] Richard S. J. Frackowiak,et al. Inhibition of L‐{18F}fluorodopa uptake into human brain by amino acids demonstrated by positron emission tomography , 1986, Annals of neurology.
[4] F. Mcdowell,et al. Plasma dopa concentrations and the “on‐off” effect after chronic treatment of Parkinson's disease , 1974, Neurology.
[5] J. Pincus,et al. Influence of dietary protein on motor fluctuations in Parkinson's disease. , 1987, Archives of neurology.
[6] K. Jellinger,et al. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. , 1973, Journal of the neurological sciences.
[7] W. Pardridge. KINETICS OF COMPETITIVE INHIBITION OF NEUTRAL AMINO ACID TRANSPORT ACROSS THE BLOOD‐BRAIN BARRIER , 1977, Journal of neurochemistry.
[8] J. Sturman,et al. TAURINE IN THE BRAIN AND LIVER OF THE DEVELOPING HUMAN AND MONKEY , 1975, Journal of neurochemistry.
[9] G. C. Cotzias,et al. Protein intake and treatment of Parkinson's disease with levodopa. , 1975, The New England journal of medicine.
[10] R. Katzman.,et al. SYNTHETIC AMINO ACIDS AND THE NATURE OF l‐DOPA TRANSPORT AT THE BLOOD‐BRAIN BARRIER , 1975, Journal of neurochemistry.
[11] A. Lieberman,et al. Parkinson's disease: a clinical review. , 1974, The American journal of the medical sciences.
[12] J. Fields,et al. Neurotransmitter receptor alterations in Parkinson's disease. , 1977, Life sciences.
[13] C. Markham,et al. Long‐term follow‐up of early dopa treatment in Parkinson's disease , 1986, Annals of neurology.
[14] Pincus Jh,et al. Dietary method for reducing fluctuations in Parkinson's disease. , 1987 .
[15] H. Pakkenberg,et al. The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). , 1985, The New England journal of medicine.
[16] O. Hornykiewicz. The mechanisms of action of L-dopa in Parkinson's disease. , 1974, Life sciences.
[17] C. Marsden,et al. SUCCESS AND PROBLEMS OF LONG-TERM LEVODOPA THERAPY IN PARKINSON'S DISEASE , 1977, The Lancet.
[18] U. Rinne,et al. Problems associated with long‐term levodopa treatment of Parkinson's disease , 1983, Acta neurologica Scandinavica. Supplementum.
[19] D. Faller,et al. NEUTRAL AMINO ACIDS IN THE BRAIN: CHANGES IN RESPONSE TO FOOD INGESTION 1 , 1978, Journal of neurochemistry.
[20] W R Woodward,et al. The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transport. , 1984, The New England journal of medicine.